Headache-related endpoints | Number of studies present (%) |
---|---|
Migraine days | 37 (80.4%) [38,39,40,41,42,43,44,45,46,47,48,49,50, 52,53,54,55,56,57,58,59, 62,63,64,65, 68,69,70, 72, 75,76,77,78, 80,81,82,83] |
Acute treatment utilization | 33 (71.7%) [38, 40,41,42,43,44, 47,48,49, 52,53,54,55, 57,58,59, 61, 62, 64,65,66,67,68,69,70,71, 77,78,79,80,81,82,83] |
Headache days | 31 (67.4%) [38, 39, 41, 43,44,45,46,47,48,49,50, 52,53,54,55,56,57, 60,61,62,63,64, 66, 67, 69,70,71,72, 74, 76, 80] |
Intensity of headache | 16 (34.8%) [38, 42,43,44, 52, 54, 57, 64, 68, 74, 76, 78,79,80, 82, 83] |
Conversion of medication overuse to non-medication overuse | |
Conversion to episodic migraine | |
Moderate to severe headache days | |
Crystal clear days | |
Severe headache days | 1 (2.2%) [63] |